A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
Clinical trial NCT05967351 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05967351
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2033-10-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.